Anti-RNF144B monoclonal antibody
Pre-made anti-RNF144B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to RNF144B/RNF144B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP1509-Ab-1/ GM-Tg-hg-IP1509-Ab-2 | Anti-Human RNF144B monoclonal antibody | Human |
GM-Tg-rg-IP1509-Ab-1/ GM-Tg-rg-IP1509-Ab-2 | Anti-Rat RNF144B monoclonal antibody | Rat |
GM-Tg-mg-IP1509-Ab-1/ GM-Tg-mg-IP1509-Ab-2 | Anti-Mouse RNF144B monoclonal antibody | Mouse |
GM-Tg-cynog-IP1509-Ab-1/ GM-Tg-cynog-IP1509-Ab-2 | Anti-Cynomolgus/ Rhesus macaque RNF144B monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP1509-Ab-1/ GM-Tg-felg-IP1509-Ab-2 | Anti-Feline RNF144B monoclonal antibody | Feline |
GM-Tg-cang-IP1509-Ab-1/ GM-Tg-cang-IP1509-Ab-2 | Anti-Canine RNF144B monoclonal antibody | Canine |
GM-Tg-bovg-IP1509-Ab-1/ GM-Tg-bovg-IP1509-Ab-2 | Anti-Bovine RNF144B monoclonal antibody | Bovine |
GM-Tg-equg-IP1509-Ab-1/ GM-Tg-equg-IP1509-Ab-2 | Anti-Equine RNF144B monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP1509-Ab-1/ GM-Tg-hg-IP1509-Ab-2; GM-Tg-rg-IP1509-Ab-1/ GM-Tg-rg-IP1509-Ab-2; GM-Tg-mg-IP1509-Ab-1/ GM-Tg-mg-IP1509-Ab-2; GM-Tg-cynog-IP1509-Ab-1/ GM-Tg-cynog-IP1509-Ab-2; GM-Tg-felg-IP1509-Ab-1/ GM-Tg-felg-IP1509-Ab-2; GM-Tg-cang-IP1509-Ab-1/ GM-Tg-cang-IP1509-Ab-2; GM-Tg-bovg-IP1509-Ab-1/ GM-Tg-bovg-IP1509-Ab-2; GM-Tg-equg-IP1509-Ab-1/ GM-Tg-equg-IP1509-Ab-2 |
Products Name | Anti-RNF144B monoclonal antibody |
Format | mab |
Target Name | RNF144B |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-RNF144B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP1509-Ag-1 | Recombinant multi-species R144B/ RNF144B/ IBRDC2 protein |
ORF Viral Vector | pGMLP001221 | human RNF144B Lentivirus plasmid |
ORF Viral Vector | vGMLP001221 | human RNF144B Lentivirus particle |
ORF Viral Vector | pGMLPm003917 | mouse Rnf144b Lentivirus plasmid |
ORF Viral Vector | vGMLPm003917 | mouse Rnf144b Lentivirus particle |
Target information
Target ID | GM-IP1509 |
Target Name | RNF144B |
Gene ID | 255488,218215,364681,705099,488237,101099205,524166,100052124 |
Gene Symbol and Synonyms | bA528A10.3,E130105P19Rik,IBRDC2,p53RFP,PIR2,RNF144B |
Uniprot Accession | Q7Z419,A5PK27 |
Uniprot Entry Name | R144B_HUMAN,R144B_BOVIN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000137393 |
Target Classification | N/A |
The target: RNF144B, gene name: RNF144B, also named as IBRDC2, PIR2, bA528A10.3, p53RFP. Enables ubiquitin-protein transferase activity. Involved in negative regulation of apoptotic process and ubiquitin-dependent protein catabolic process. Located in mitochondrial membrane. [provided by Alliance of Genome Resources, Apr 2022].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.